Author + information
- Received May 27, 2009
- Revision received August 18, 2009
- Accepted September 17, 2009
- Published online February 1, 2010.
- Navtej S. Chahal, MD and
- Roxy Senior, MD, DM⁎ ()
- ↵⁎Reprint requests and correspondence:
Prof. Roxy Senior, Department of Cardiovascular Medicine, Northwick Park Hospital, Harrow HA1 3UJ, United Kingdom
The significant advances made in ultrasound microbubble technology now permits reliable, reproducible left ventricular opacification, and this review reiterates the evidence that has shown contrast echocardiography to be clinically effective, to reduce downstream costs and to spare patients further, potentially hazardous investigations. Despite the evidence and the advances, there remains ambivalence towards the administration of contrast agents in echocardiography laboratories throughout the world, particularly in the performance of rest studies. Therefore, this review also addresses some of the reasons for the suboptimal uptake of contrast agents and encourages physicians, sonographers, and accreditatory bodies to adopt a different approach towards the difficult-to-image patient.
Professor Senior has received research grants from Bracco Imaging (Milan, Italy). Sanjiv Kaul, MD, served as Guest Editor for this article.
- Received May 27, 2009.
- Revision received August 18, 2009.
- Accepted September 17, 2009.
- American College of Cardiology Foundation
- Principles of Contrast Imaging
- Approved Contrast Agents
- Clinical Applications of LV Opacification
- Clinical Efficacy of Contrast-Enhanced Stress Echocardiography
- Can Rest Contrast Imaging Have a “Clinical Impact”?
- Cost Efficiency of Contrast Agents
- The Ambivalence Towards Contrast Agents